Reproduction is the biological process that perpetuates life, but it is also the site of some of India's most sensitive policy intersections — sex determination and the PCPNDT Act, surrogacy regulation, reproductive rights, family planning, and maternal health. UPSC GS2 questions on health policy and GS1 questions on social issues (gender, women's empowerment) draw on the biology of reproduction. Understanding the science enables a sharper policy analysis.
PART 1 — Quick Reference Tables
Asexual Reproduction — Methods
| Method | Description | Examples |
|---|---|---|
| Binary fission | Single organism divides into two equal halves | Amoeba (multiple planes), Paramecium (transverse), Bacteria |
| Multiple fission | Multiple divisions simultaneously; form many daughter cells | Plasmodium (malaria parasite — forms many merozoites) |
| Budding | Small outgrowth (bud) develops into new organism | Hydra, Yeast |
| Fragmentation | Body breaks into fragments, each grows into new organism | Planaria (flatworm), Spirogyra (alga) |
| Regeneration | Ability to regrow entire organism from body parts | Planaria (cut into pieces — each regenerates), Starfish |
| Spore formation | Production of spores in sporangia | Rhizopus (bread mould), Ferns, Mosses |
| Vegetative propagation | New plants from vegetative parts (roots, stems, leaves) | See table below |
Vegetative Propagation — Natural and Artificial
| Type | Method | Example |
|---|---|---|
| Natural — Runners/stolons | Horizontal stems that root at nodes | Strawberry, Grass |
| Natural — Rhizomes | Underground horizontal stems | Ginger, Turmeric, Lotus |
| Natural — Tubers | Swollen underground stems | Potato (with eyes/buds) |
| Natural — Bulbs | Short stem with fleshy leaves | Onion, Garlic |
| Natural — Leaf buds | Adventitious buds on leaves | Bryophyllum (miracle leaf) |
| Artificial — Cutting | Stem/leaf cutting planted in soil | Rose, Sugarcane, Bougainvillea |
| Artificial — Grafting | Scion (desired variety) joined to rootstock | Mango, Apple, Guava |
| Artificial — Layering | Branch rooted while still attached to parent | Jasmine, Strawberry |
| Artificial — Tissue culture | Cells grown in sterile nutrient medium | Banana, Potato, Orchid |
Sexual Reproduction in Flowering Plants
| Event | Location | Description |
|---|---|---|
| Pollination | Flower | Transfer of pollen from anther to stigma |
| Germination of pollen | Stigma | Pollen grain germinates; pollen tube grows down style |
| Fertilisation | Ovule | Pollen tube reaches ovule; two male gametes released |
| Double fertilisation | Ovule | One male gamete + egg cell → zygote (embryo); second male gamete + two polar nuclei → triploid endosperm (food reserve) |
| Development | Ovary | Zygote → embryo; ovule → seed; ovary wall → fruit |
Human Reproductive System
| Structure | Sex | Function |
|---|---|---|
| Testes | Male | Produce sperm (spermatogenesis) and testosterone |
| Epididymis | Male | Sperm maturation and storage |
| Vas deferens | Male | Sperm transport |
| Seminal vesicles, prostate, Cowper's glands | Male | Produce secretions that form semen |
| Urethra/penis | Male | Sperm delivery |
| Ovaries | Female | Produce eggs (oogenesis) and hormones (oestrogen, progesterone) |
| Fallopian tubes (oviducts) | Female | Egg transport; site of fertilisation |
| Uterus | Female | Implantation; development of embryo/foetus |
| Cervix | Female | Lower uterus; dilates during labour |
| Vagina | Female | Birth canal; receives semen |
PART 2 — Detailed Notes
1. Why Reproduce?
Reproduction perpetuates the species. Unlike other life processes, reproduction is not necessary for individual survival but is essential for species survival. Two modes: asexual (one parent, genetically identical offspring) and sexual (two parents, genetic recombination → variation).
Asexual reproduction produces clones — genetically identical to parent. Rapid population increase but no genetic variation → reduced adaptability to changing environments.
Sexual reproduction introduces genetic variation through meiosis and fertilisation. This variation is the raw material for natural selection and evolution. Though slower, sexual reproduction gives species the flexibility to adapt.
2. Asexual Reproduction — Examples
Hydra (Budding): Hydra is a simple freshwater animal. Under good conditions, it reproduces by budding: a small outgrowth develops on the body wall, grows a mouth and tentacles, and eventually separates. Under adverse conditions, Hydra reproduces sexually.
Planaria (Fragmentation + Regeneration): Planaria can be cut into multiple pieces and each piece will regenerate into a complete organism. This remarkable ability is due to neoblasts — stem cells distributed throughout the body.
Spirogyra (Fragmentation): The filamentous green alga simply breaks apart; each fragment grows into a new filament.
Rhizopus (Spore formation): Common bread mould. Spores are produced in sporangia at the tip of vertical hyphae. Spores are lightweight, airborne, and can survive harsh conditions — explaining why bread moulds so rapidly.
Vegetative propagation is economically important:
- Tissue culture (micropropagation): Plants grown from tiny explants in sterile nutrient medium under controlled conditions. Advantages: can produce thousands of plants from a single parent; produces disease-free plants (meristem culture eliminates viruses); preserves elite genotypes; enables year-round production regardless of season.
- Used commercially for: bananas, potatoes, strawberries, orchids, sugar cane, timber trees.
3. Sexual Reproduction in Flowering Plants
Flower structure: The flower is the reproductive organ of angiosperms.
- Stamen (male): Filament + anther (produces pollen = male gametophyte)
- Pistil/Carpel (female): Stigma (receives pollen) + Style (pollen tube grows through) + Ovary (contains ovule with egg cell)
- Petals: Attract pollinators
- Sepals: Protect flower bud
Pollination:
- Self-pollination: Pollen transferred to stigma of same flower or same plant. Maintains genetic consistency. Used in crop breeding for pure lines.
- Cross-pollination: Pollen transferred to stigma of a different plant. Achieved by wind (anemophily), water (hydrophily), insects (entomophily), birds (ornithophily), or bats (chiropterophily). Promotes genetic variation.
Double fertilisation — unique to angiosperms: One pollen grain contains two male gametes. Both reach the ovule via the pollen tube. First fertilisation: One male gamete + egg cell → diploid zygote (2n) → embryo. Second fertilisation: Second male gamete + two polar nuclei → triploid endosperm (3n) — provides nutrition for developing embryo. This is called double fertilisation (discovered by Nawaschin in 1898).
After fertilisation: ovule → seed; ovary → fruit; sepals/petals/stamens → wither and fall.
🎯 UPSC Connect: Pollination and Food Security
Bees and other pollinators enable reproduction in about 75% of crop species globally. The global decline of bee populations (due to habitat loss, pesticides — especially neonicotinoids, parasites like Varroa mites, and disease) threatens agricultural production. The Convention on Biological Diversity (CBD) and IPBES (Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services) have highlighted pollinator decline as a major food security threat.
4. Human Reproductive System
Male reproductive system: Testes are located outside the body in the scrotum — sperm production (spermatogenesis) requires a temperature slightly below body temperature (~35°C vs 37°C body temperature). Testosterone (produced by Leydig cells in testes) drives male secondary sexual characteristics (beard growth, voice change, muscle development) and sperm production.
Sperm production: Spermatogonia → (meiosis + differentiation) → spermatids → spermatozoa (sperm). Each sperm: head (containing DNA), midpiece (packed with mitochondria for energy), tail (flagellum for swimming).
Female reproductive system: Ovaries produce eggs (oogenesis) and hormones (oestrogen, progesterone). Unlike sperm (produced continuously from puberty), a female is born with all the egg cells she will ever have (~1–2 million oocytes at birth, reducing to ~400,000 at puberty, ~400 actually ovulated in a lifetime).
Menstrual cycle (approximately 28 days):
- Day 1–5 (Menstruation): Uterine lining (endometrium) sheds as the corpus luteum degenerates and progesterone falls.
- Day 6–13 (Follicular/Proliferative phase): FSH from pituitary stimulates follicle development in ovary; oestrogen rises; endometrium thickens.
- Day 14 (Ovulation): LH surge triggers release of egg from follicle. The egg is swept into the fallopian tube.
- Day 15–28 (Luteal/Secretory phase): Empty follicle becomes corpus luteum; secretes progesterone; endometrium prepares for implantation. If no fertilisation, corpus luteum degenerates → progesterone falls → menstruation.
Fertilisation and development: Fertilisation typically occurs in the fallopian tube within 24–48 hours of ovulation. The fertilised egg (zygote) undergoes repeated cell divisions (cleavage) while moving to the uterus. By day 5–6, it is a blastocyst that implants in the endometrium. The placenta forms from embryonic and maternal tissues — it exchanges nutrients, O2, hormones, and waste between mother and foetus. The placenta also produces hCG (human chorionic gonadotropin) — detected by pregnancy tests.
5. Reproductive Health
Contraceptive methods:
- Barrier: Condom (male/female), diaphragm — prevent sperm reaching egg; condoms also prevent STIs
- Hormonal: Oral contraceptive pills (oestrogen + progesterone suppress ovulation); injectable DMPA; hormonal IUD
- Intrauterine Devices (IUDs): Copper-T — creates unfavourable uterine environment; effective for 5–10 years
- Permanent: Vasectomy (male — cutting/sealing vas deferens); tubectomy (female — fallopian tube ligation)
- Emergency contraception: Levonorgestrel pill within 72 hours of unprotected sex
Sexually Transmitted Infections (STIs):
- Bacterial: Gonorrhoea (Neisseria gonorrhoeae), Syphilis (Treponema pallidum), Chlamydia
- Viral: HIV/AIDS, Genital herpes (HSV), HPV (human papillomavirus — causes genital warts and cervical cancer), Hepatitis B
- Treatable: bacterial STIs (antibiotics); Hepatitis B and HPV (preventable by vaccines)
[Additional] India's National HPV Vaccination Programme (GS2 — Health):
HPV (Human Papillomavirus) causes nearly all cases of cervical cancer. India accounts for ~25% of the world's cervical cancer deaths — ~80,000 new cases and ~42,000 deaths annually. Cervical cancer is the 2nd most common cancer among Indian women.
India launched the nationwide HPV vaccination programme on February 28, 2025 (PM Modi). Key details:
- Target group: Girls turning 14 years (adolescents); ~1.2 crore girls per year
- Vaccine: Single dose of Gardasil (quadrivalent HPV vaccine — protects against HPV types 6, 11, 16, 18); reduces cervical cancer risk by >85% when given in teenage years before exposure
- Cost: Free of cost at Ayushman Arogya Mandirs and district hospitals; voluntary
- Procurement: 2.6 crore doses committed under Gavi (Vaccine Alliance) partnership; ~1.5 crore already delivered
- Budget mention: Union Budget 2024 encouraged HPV vaccination for girls aged 9-14
UPSC angles:
- Preventive healthcare > curative (vaccination vs cancer treatment cost)
- Women's health equity — cervical cancer disproportionately affects poor, rural women (less access to screening, later diagnosis)
- Adolescent health policy — Universal Immunisation Programme (UIP) now covers adolescents beyond infants
- Connection: HPV → cervical cancer → PCPNDT linkage (female health focus); SDG 3.4 (NCD prevention)
Cervical cancer screening: Pap smear (detects abnormal cells before cancer) and HPV DNA test are available at government facilities but awareness and access remain limited. WHO's "90-70-90 strategy" to eliminate cervical cancer as a public health problem targets: 90% HPV vaccination, 70% screening, 90% treatment of detected cases.
🎯 UPSC Connect: Reproductive Rights and Policy
PCPNDT Act 1994 (Pre-Conception and Pre-Natal Diagnostic Techniques Act): Prohibits sex-selective abortion and use of prenatal diagnosis to determine sex of foetus. India's sex ratio at birth improved from 918 (2001) to 934 (2011) to 929 (2019–21 NFHS-5) — but "son preference" persists.
Assisted Reproductive Technology (ART) Regulation Act 2021 and Surrogacy (Regulation) Act 2021: India had become the "surrogacy capital of the world" with largely unregulated commercial surrogacy. These two Acts now:
- Prohibit commercial surrogacy; allow only altruistic surrogacy (by close relative)
- Regulate ART clinics and banks
- Protect the rights of the surrogate mother and child
Family Planning 2030: India became a co-host of the Family Planning 2020 (FP2020) initiative. Under FP2030, India commits to ensuring access to voluntary family planning services across all districts, especially in high-fertility states (UP, Bihar).
Mission Parivar Vikas: Focused on 7 high-fertility states (UP, Bihar, MP, Rajasthan, Jharkhand, Chhattisgarh, Assam) — India's total fertility rate (TFR) is now 2.0 nationally (NFHS-5, 2019–21), below the replacement level of 2.1 for the first time.
PART 3 — Frameworks & Analysis
Framework: Reproduction Policy Ecosystem
| Issue | Legislation/Policy | Key Provision |
|---|---|---|
| Sex-selective abortion | PCPNDT Act 1994 (amended 2003) | Bans prenatal sex determination; mandates registration of all ultrasound centres |
| Surrogacy | Surrogacy (Regulation) Act 2021 | Only altruistic surrogacy by close relative allowed |
| ART regulation | ART (Regulation) Act 2021 | Registers and regulates IVF clinics, egg/sperm banks |
| Abortion rights | Medical Termination of Pregnancy (MTP) Act 1971, amended 2021 | Extends abortion access to 24 weeks for specific categories; removes upper limit in case of foetal abnormality |
| Maternal health | Janani Suraksha Yojana (JSY), Janani Shishu Suraksha Karyakram (JSSK) | Institutional delivery; free transport, drugs, and food during delivery |
[Additional] 8a. Maternal Mortality in India — From Placenta Biology to MMR Reduction
The chapter covers implantation, placenta formation, and foetal development. The placenta is the life-support system of pregnancy — but placental failure, haemorrhage, and infection are also the leading causes of maternal death. India's dramatic reduction in maternal mortality (from 254 in 2004–06 to 88 in 2021–23) is one of the great public health successes of the last two decades — and understanding why requires the biology this chapter teaches.
How pregnancy complications connect to the chapter's biology:
| Complication | Biological mechanism | Share of maternal deaths |
|---|---|---|
| Postpartum haemorrhage | Uterus fails to contract after delivery (uterine atony); or placenta praevia (placenta implants over cervix, blocks normal delivery) → massive bleeding | ~21–27% |
| Eclampsia/pre-eclampsia | Abnormal placental blood vessels → systemic inflammation → high blood pressure + convulsions + organ failure during pregnancy | ~29% nationally (FOGSI study; eclampsia is #1 cause in eastern India at 43%) |
| Sepsis/infection | Post-delivery infection through birth canal or uterus — especially in home deliveries without sterile conditions | ~15% |
| Obstructed labour | Foetus too large or malpositioned to pass through birth canal without skilled intervention; rupture of uterus | ~8–10% |
All four are largely preventable with skilled birth attendance and institutional delivery — the exact goal of India's Janani Suraksha Yojana (JSY).
[Additional] India's Maternal Mortality — Progress, Plateau, and Disparity (GS2 — Health / GS1 — Social Issues):
India's MMR trajectory (SRS Special Bulletins, Office of Registrar General of India, MHA):
| Period | MMR (per 1,00,000 live births) |
|---|---|
| 2014-16 | 130 |
| 2019-21 | 93 |
| 2020-22 | 88 |
| 2021-23 | 88 (latest; released September 2025) |
India achieved its National Health Policy 2017 target of MMR < 100 ahead of schedule. The SDG 3.1 target is ≤ 70 per lakh live births by 2030. With India's MMR at 88 and plateaued for two consecutive reporting rounds, reaching 70 by 2030 requires renewed acceleration.
State disparity — the starkest UPSC angle (SRS 2021-23):
- Kerala: 20 — lowest in India; met SDG target years ago; strong institutional delivery infrastructure, trained ANM and midwife network
- Tamil Nadu: 49, Andhra Pradesh: 46, Maharashtra: 38 — southern/western states performing well
- Assam: ~10x Kerala's MMR — the SRS 2021-23 bulletin shows Assam's MMR is approximately ten times that of Kerala (Kerala = 20)
- Odisha: 153 — one of the highest; 8 Empowered Action Group (EAG) states (UP, Bihar, Rajasthan, MP, Chhattisgarh, Jharkhand, Odisha, Uttarakhand) historically account for the majority of India's maternal deaths despite improving rates
8 states have already achieved the SDG-3.1 target of ≤ 70 per lakh live births, all from southern and western India.
Janani Suraksha Yojana (JSY) — the policy mechanism: JSY (launched 2005, under NHM) provides a conditional cash transfer to pregnant women in Low Performing States (LPS) to incentivise institutional delivery:
- FY 2023-24: 1.02 crore (102.55 lakh) women received JSY benefits
- FY 2024-25 (provisional): 94.80 lakh beneficiaries
- Studies confirm JSY increased institutional delivery rates by 42.6% in surveyed areas post-launch
- Works through ASHA workers — each ASHA accompanies the pregnant woman to hospital, ensures post-natal care, and tracks newborn immunisation
- Complementary: Janani Shishu Suraksha Karyakram (JSSK): Free drugs, blood transfusion, transport, and food for pregnant women and sick newborns in government facilities
UPSC synthesis: MMR connects the chapter's placenta and delivery biology to India's governance story — from unregulated home deliveries causing sepsis and haemorrhage deaths, to JSY creating financial incentives for hospital delivery, to ASHAs as the last-mile health worker. The Kerala-Assam gap is a governance and equity question: same biological processes, vastly different health outcomes due to infrastructure, literacy, and institutional capacity differences.
[Additional] 8b. IVF Technology and India's Fertility Crisis
The chapter teaches in vivo fertilisation in the fallopian tube. In vitro fertilisation (IVF) replicates this outside the body — eggs are retrieved from ovaries, mixed with sperm in a laboratory dish ("in vitro" = in glass), the resulting embryos are cultured for 3–5 days, and the best-quality embryo is transferred to the uterus. India has the world's second-largest fertility industry, now regulated under the ART Act 2021.
IVF — Step-by-Step Biology:
- Ovarian stimulation: Patient receives FSH/LH injections (same hormones that the chapter covers for the menstrual cycle) to stimulate multiple follicles to mature simultaneously (unlike the natural single egg)
- Egg retrieval (Oocyte Pick-Up): Under ultrasound guidance, a needle retrieves mature eggs from follicles (replacing the natural ovulation step)
- Fertilisation: Eggs are placed with prepared sperm in a laboratory dish; if sperm motility is poor, a single sperm is injected directly into the egg by ICSI (Intracytoplasmic Sperm Injection) — applicable for male factor infertility
- Embryo culture: Fertilised eggs (zygotes) divide in a controlled incubator environment; embryologist selects the best-quality embryo at the blastocyst stage (Day 5–6)
- Embryo transfer: Selected embryo is placed inside the uterus using a thin catheter; progesterone support continues to prepare the endometrium for implantation
- Implantation (or failure): Success is confirmed by hCG (pregnancy hormone) detection ~14 days later
IVF success rate at experienced centres: approximately 40–60% per cycle for women under 35; drops to 10–20% for women above 40 (eggs age → chromosomal errors increase).
[Additional] India's Fertility Industry and ART Act 2021 (GS2 — Health / Social Issues / Law):
India's infertility burden:
- India carries an estimated 25% of the global burden of infertility
- Approximately 27.5 million couples in India are estimated to be infertile (frequently cited estimate; NFHS-5 infertility prevalence: 18.7 per 1,000 married women over 5 years)
- India conducts approximately 2–2.5 lakh IVF cycles per year — one of the highest globally; market size ~USD 2.35 billion (2024), growing at ~16% CAGR
Causes of rising infertility — the environmental connection:
- Male factor infertility: 50% of infertility cases have a male factor; in 30% of cases, male factor is the sole reason (ICMR Standard Treatment Workflow)
- Global sperm count decline: A 2022 meta-analysis (Levine et al., Human Reproduction Update, Oxford Academic; data from 53 countries including Asia and India) found >50% decline in total sperm counts over 46 years, accelerating at −2.48% per year post-2000. Factors: endocrine-disrupting chemicals (pesticides, BPA in plastics — connecting to the chapter's discussion on chemical pollution), sedentary lifestyle, obesity, heat exposure, air pollution
- Female factor: Rising rates of PCOS (polycystic ovary syndrome), endometriosis, tubal damage from untreated STIs, delayed childbearing with age-related fertility decline
ART Act 2021 — implementation status:
- Assisted Reproductive Technology (Regulation) Act 2021 (notified January 2022): Regulates all IVF clinics, sperm banks, egg donor programmes; bans sex selection for non-medical reasons; mandates registration with the National ART and Surrogacy Registry
- National ART and Surrogacy Registry: Set up April 2022; National Board constituted May 2022
- Implementation gap: As of May 2023, only 219 out of 444 ART clinics had received formal registration — fewer than half, despite registration being mandatory within 60 days of Registry notification. This is a textbook "legislation-implementation gap" for UPSC Mains.
- Key protections: Egg donors limited to 6 donations per lifetime; embryo storage rules; gamete donor consent requirements; bans on commercial egg/sperm sale
UPSC synthesis: IVF connects the chapter's fertilisation and embryo development biology to India's largest regulated private healthcare sector (ART Act 2021), the global environmental health crisis of sperm count decline (endocrine disruptors — GS3 environment), gender equity (male infertility stigma vs. social burden placed on women), and implementation of complex legislation. The Levine 2022 meta-analysis on sperm decline is a contemporary science-policy link that appears in Indian current affairs through its implications for reproductive health policy.
[Additional] 8b. ART and Surrogacy (Regulation) Acts 2021 — India's IVF Governance
The chapter covers human reproduction and briefly mentions IVF and other assisted techniques. It does not explain India's legal regulatory framework governing IVF clinics, donor gametes, and surrogacy — a Prelims and Mains GS2 (Health/Ethics) priority.
Key Terms — ART and Surrogacy:
| Term | Meaning |
|---|---|
| ART (Assisted Reproductive Technology) | All medical techniques used to address infertility — IVF (In-Vitro Fertilisation), ICSI (Intracytoplasmic Sperm Injection), gamete donation, embryo transfer |
| IVF (In-Vitro Fertilisation) | Egg + sperm combined in laboratory dish; resulting embryo transferred to woman's uterus; the central NCERT-mentioned ART procedure |
| Altruistic Surrogacy | Surrogate carries pregnancy WITHOUT monetary compensation (only medical + insurance covered); the ONLY form of surrogacy legal in India |
| Commercial Surrogacy | Surrogate paid beyond medical expenses; BANNED in India under the Surrogacy Act 2021 |
| Intending Couple | The couple seeking surrogacy services; must be Indian, married, with proven infertility |
| Surrogate Mother | Married woman, age 25-35, with at least one biological child; eligible to be surrogate only once in her lifetime; must be a close relative of intending couple |
| ICMR (Indian Council of Medical Research) | Maintains the National Registry of ART clinics and banks under the ART Act |
[Additional] ART and Surrogacy Acts — India's Reproductive Rights Governance (GS2 — Health / Social Justice / Ethics):
The two laws — passed together December 2021:
| Law | Assent date | Effective date | Scope |
|---|---|---|---|
| Surrogacy (Regulation) Act, 2021 | 25 December 2021 | 25 January 2022 | Regulates surrogacy practice; bans commercial surrogacy |
| Assisted Reproductive Technology (Regulation) Act, 2021 | 18 December 2021 | January 2022 | Regulates IVF clinics, gamete banks, ART procedures |
| Implementing ministry | Ministry of Health and Family Welfare (MoHFW) |
Key provisions of the Surrogacy Act 2021:
| Provision | Detail |
|---|---|
| Permitted form | ONLY altruistic surrogacy — no payment to surrogate beyond medical expenses + insurance |
| Eligibility of intending couple | Indian married couple; woman 23-50 years, man 26-55 years; proven medical infertility; OCIs included |
| Single women eligible | Single Indian widow or divorcee aged 35-45 years (added via amendment) |
| Single men barred | NOT permitted |
| Same-sex couples barred | NOT permitted |
| Eligibility of surrogate | Married woman, 25-35 years, at least one biological child, surrogate only once in lifetime, close relative of intending couple |
| Insurance | Surrogate must be covered by 36-month insurance |
| Foreigners | BARRED from surrogacy in India |
| Penalty | Up to 10 years imprisonment + ₹10 lakh fine for commercial surrogacy |
2024 Amendment — Surrogacy Rules:
| Aspect | Pre-Amendment | Post-Amendment (21 Feb 2024) |
|---|---|---|
| Donor gametes | Both gametes had to be from intending couple (genetic connection required) | One donor gamete (egg OR sperm) permitted if Medical Board certifies medical necessity for the intending parent |
| Trigger | After Supreme Court interventions noting medical needs of couples | MoHFW notification 21 February 2024 |
| Significance | Restores access for couples where one partner cannot produce viable gametes due to medical reasons |
Key provisions of the ART Act 2021:
| Provision | Detail |
|---|---|
| Coverage | All ART clinics, ART banks, gamete donors, commissioning couples |
| Registration | Every ART clinic and bank must register with National Registry (ICMR) |
| Donor regulations | Eligibility, screening, anonymity, limits on number of donations (gamete donor: max 7 children worldwide) |
| Embryo storage | Maximum 10 years |
| Single women | Eligible for ART services (NOT just widows/divorcees as in Surrogacy Act) |
| Same-sex couples | NOT explicitly permitted under either Act |
| Pre-conception sex selection | PROHIBITED under both Acts (consistent with PCPNDT Act 1994) |
| Penalty | Pre-natal sex determination via ART = up to ₹10 lakh fine + 5 years imprisonment |
Governance structure:
| Body | Role |
|---|---|
| National Assisted Reproductive Technology and Surrogacy Board | Apex national body; chair = Union Health Minister; advisory + policy oversight |
| State Assisted Reproductive Technology and Surrogacy Boards | State-level enforcement and registration |
| National Registry (maintained by ICMR) | Central database of all ART clinics, banks, procedures |
Why these laws — context:
| Issue | Background |
|---|---|
| Commercial surrogacy industry | India was a global hub for paid surrogacy — estimated US$2 billion/year before 2015 restrictions; reproductive exploitation of poor women |
| Exploitation concerns | Surrogates often paid <10% of total cost; medical risks; lack of legal protection |
| Anonymous gametes & abandonment | Foreign couples abandoning surrogate babies (e.g., Manji Yamada case 2008 Japan-India) |
| 2015 ban on foreign surrogacy | Government banned foreigners from commercial surrogacy (precursor to 2021 Act) |
UPSC synthesis: Key exam facts: Two separate Acts — Surrogacy (Regulation) Act 2021 (assent 25 Dec 2021, effective 25 Jan 2022) + ART (Regulation) Act 2021 (assent 18 Dec 2021); both administered by MoHFW; ONLY altruistic surrogacy permitted = commercial surrogacy BANNED with penalty up to 10 years + ₹10 lakh; eligibility: intending couple (woman 23-50, man 26-55, proven infertility); single Indian widow/divorcee 35-45 allowed for surrogacy; single men + same-sex couples BARRED; surrogate must be 25-35, married, one biological child, surrogate ONCE in lifetime, close relative; 2024 Amendment (notified 21 Feb 2024) allows ONE donor gamete on medical necessity; National Registry maintained by ICMR; National Board chaired by Union Health Minister. Prelims trap: TWO separate Acts (ART Act + Surrogacy Act) — NOT one combined law; commercial surrogacy = BANNED (only altruistic = permitted); single Indian women are NOT eligible — only widows or divorcees in 35-45 age range; ONLY widow/divorcee single women allowed for surrogacy (NOT all single women — that is the ART Act); penalty for commercial surrogacy = up to 10 years + ₹10 lakh (often confused with PCPNDT Act penalties); 2024 Amendment date = 21 February 2024 (MoHFW notification).
Exam Strategy
Prelims traps:
- Double fertilisation is unique to angiosperms — not gymnosperms, not animals.
- Endosperm is triploid (3n), not diploid. The embryo is diploid (2n).
- Vasectomy is a male sterilisation procedure (vas deferens); tubectomy/tubal ligation is female.
- Plasmodium reproduces by multiple fission (forming many merozoites at once) — not binary fission.
- The MTP Act 2021 amendment extended the upper limit for abortion to 24 weeks for certain women (rape survivors, differently abled women, etc.), not all — and removed the gestational limit entirely for cases of foetal abnormalities.
Mains frameworks:
- Surrogacy debate: biology of reproduction → commercial surrogacy growth → ethical concerns → Surrogacy Act 2021 → implications for reproductive rights
- Sex ratio: PCPNDT Act → gender preference → Beti Bachao Beti Padhao → NFHS-5 data
- Maternal health: reproductive biology → maternal mortality → JSY/JSSK → institutional delivery rates
Practice Questions
Q1 (Prelims 2023): With reference to the "Surrogacy (Regulation) Act, 2021", consider the following statements… (Tests: nature of surrogacy allowed, eligibility, compensation rules)
Q2 (Prelims 2020): With reference to the PCPNDT Act, which of the following are offences under the Act? (Tests provisions of the Act — rooted in biology of prenatal sex determination)
Q3 (Mains GS2 2022): The Assisted Reproductive Technology (Regulation) Act, 2021 is a significant legislation. Examine its provisions and implications for women's reproductive rights in India.
Q4 (Mains GS1 2019): How is the sex ratio at birth in India changing? Discuss the factors responsible and measures needed. Biology of sex determination (XX/XY) → PCPNDT Act → Beti Bachao programme → NFHS data
BharatNotes